Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

ALLERGOLOGISK INDEKLIMA DIAGNOSTIK ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5%   Bankruptcy risk   4.0% 4.3% 4.6% 2.3% 3.5% 3.0% 11.8% 11.6%   Credit score (0-100)   51 49 46 63 53 56 20 21   Credit rating   BBB BBB BBB BBB BBB BBB BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   650 106 142 205 342 248 0.0 0.0   EBITDA   354 -68.8 -35.0 27.5 215 4.1 0.0 0.0   EBIT   354 -68.8 -35.0 27.5 215 4.1 0.0 0.0   Pre-tax profit (PTP)   68.0 107.1 52.1 357.9 0.0 188.4 0.0 0.0   Net earnings   64.1 84.9 73.2 278.9 -0.3 136.6 0.0 0.0   Pre-tax profit without non-rec. items   68.0 107 94.3 358 0.0 188 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   331 221 183 73.0 130 116 0.0 0.0   Shareholders equity total   2,484 2,515 2,533 2,755 2,698 2,776 2,590 2,590   Interest-bearing liabilities   3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   2,502 2,543 2,597 2,857 2,749 2,796 2,590 2,590   Net Debt   -1,950 -2,127 -2,192 -2,455 -2,307 -2,401 -2,590 -2,590     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   650 106 142 205 342 248 0.0 0.0   Gross profit growth   -14.3% -83.7% 33.9% 44.4% 67.4% -27.6% -100.0% 0.0%   Employees   0 0 0 0 0 1 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   2,502 2,543 2,597 2,857 2,749 2,796 2,590 2,590   Balance sheet change%   -5.4% 1.7% 2.1% 10.0% -3.8% 1.7% -7.4% 0.0%   Added value   354.2 -68.8 -35.0 27.5 215.3 4.1 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -60 -110 -38 -110 57 -14 -116 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   2.0 -1.0 -2.0 1.0 2.0 3.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   54.5% -65.0% -24.7% 13.4% 62.9% 1.6% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   15.6% 4.2% 3.7% 13.2% 10.9% 7.1% 0.0% 0.0%   ROI %   16.2% 4.3% 3.8% 13.6% 11.2% 7.1% 0.0% 0.0%   ROE %   2.6% 3.4% 2.9% 10.5% -0.0% 5.0% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   99.3% 98.9% 97.5% 96.5% 98.1% 99.3% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -550.4% 3,092.2% 6,268.2% -8,928.7% -1,071.3% -58,818.6% 0.0% 0.0%   Gearing %   0.2% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   8,789.6% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   125.4 82.7 37.7 27.5 51.2 132.4 0.0 0.0   Current Ratio   125.4 82.7 37.7 27.5 51.2 132.4 0.0 0.0   Cash and cash equivalent   1,953.4 2,126.6 2,192.3 2,455.5 2,306.9 2,401.0 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   715.2 728.9 659.9 489.3 541.2 558.6 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 0 0 0 0 4 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 0 0 0 4 0 0   EBIT / employee   0 0 0 0 0 4 0 0   Net earnings / employee   0 0 0 0 0 137 0 0